HER2 Support Group Forums - View Single Post - I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Can

'lizbeth · 07-13-2013, 11:51 AM

http://www.clinicaltrials.gov/ct2/sh...y+stage&rank=8

Drug: Neratinib
Drug: ABT-888
Drug: Standard Therapy
Drug: AMG 386
Drug: AMG 479 (Ganitumab) plus Metformin
Drug: MK-2206 with or without Trastuzumab
Drug: AMG 386 and Trastuzumab
Drug: T-DM1 and Pertuzumab
Drug: Pertuzumab and Trastuzumab

I-Spy is in Phase II and could be a great opportunity for someone to receive less toxic treatment and improve standard of care.

07-13-2013, 11:51 AM	#1
'lizbeth Senior Member Join Date: Apr 2008 Location: Sunny San Diego Posts: 2,214	I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Can http://www.clinicaltrials.gov/ct2/sh...y+stage&rank=8 Drug: Neratinib Drug: ABT-888 Drug: Standard Therapy Drug: AMG 386 Drug: AMG 479 (Ganitumab) plus Metformin Drug: MK-2206 with or without Trastuzumab Drug: AMG 386 and Trastuzumab Drug: T-DM1 and Pertuzumab Drug: Pertuzumab and Trastuzumab I-Spy is in Phase II and could be a great opportunity for someone to receive less toxic treatment and improve standard of care. __________________ Diagnosed 2007 Stage IIb Invasive Ductal Carcinoma, Pagets, 3 of 15 positive nodes Traditional Treatment: Mastectomy and Axillary Node Dissection followed by Taxotere, 6 treatments and 1 year of Herceptin, no radiation Former Chemo Ninja "Takizi Zukuchiri" Additional treatments: GP2 vaccine, San Antonio Med Ctr Prescriptive Exercise for Cancer Patients ENERGY Study, UCSD La Jolla Reconstruction: TRAM flap, partial loss, Revision The content of my posts are meant for informational purposes only. The medical information is intended for general information only and should not be used in any way to diagnose, treat, cure, or prevent disease